Heinz Läubli Jürgen Hench Michal Stanczak Ingmar Heijnen Alexandros Papachristofilou Stephan Frank Alfred Zippelius Frank Stenner-Liewen
10.1186/s40425-017-0249-y
J Immunother Cancer
2017 Jun 20;5:46.
antibody autoimmune brain metastasis cancer immunotherapy checkpoint inhibitor
CC BY
https://pubmed.ncbi.nlm.nih.gov/28642817/
Adenocarcinoma / secondary Brain Neoplasms / secondary Lung Neoplasms / drug therapy Programmed Cell Death 1 Receptor / antagonists & inhibitors Vasculitis, Central Nervous System / diagnostic imaging
Adenocarcinoma / secondary Brain Neoplasms / secondary Lung Neoplasms / drug therapy Programmed Cell Death 1 Receptor / antagonists & inhibitors Vasculitis, Central Nervous System / diagnostic imaging Case Reports Adenocarcinoma / diagnosis Adenocarcinoma / drug therapy Antibodies, Monoclonal / adverse effects Antineoplastic Agents / adverse effects Brain Neoplasms / diagnosis Diagnosis, Differential Disease Progression Humans Immunotherapy / adverse effects Immunotherapy / methods Magnetic Resonance Imaging Male Middle Aged Nivolumab Vasculitis, Central Nervous System / chemically induced Vasculitis, Central Nervous System / pathology Antibodies, Monoclonal Antineoplastic Agents PDCD1 protein, human Programmed Cell Death 1 Receptor Nivolumab
PMC5477093
28642817
Cerebral vasculitis mimicking intracranial metastatic progression of lung cancer during PD-1 blockade
2017